Cargando…
Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of Medicine
Hepatic epithelioid hemangioendothelioma (HEH) is extremely rare, occurring in 1 to 2 per 100,000, with chemotherapy options not well defined. Our case involved a 49-year-old female who had hepatic masses and metastasis to the lungs with a liver biopsy revealing HEH. After developing a rash from sor...
Autores principales: | Soape, Matthew P., Verma, Rashmi, Payne, J. Drew, Wachtel, Mitchell, Hardwicke, Fred, Cobos, Everardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488146/ https://www.ncbi.nlm.nih.gov/pubmed/26167310 http://dx.doi.org/10.1155/2015/326795 |
Ejemplares similares
-
Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report
por: Raphael, Claire, et al.
Publicado: (2010) -
Epithelioid Hemangioendothelioma of Nasal Cavity
por: Patnayak, Rashmi, et al.
Publicado: (2010) -
Hepatic epithelioid hemangioendothelioma: is it actually “indolent”?
por: Yang, Alexander H., et al.
Publicado: (2023) -
Epithelioid hemangioendothelioma of the spine: an analysis of imaging findings
por: Chen, Yongye, et al.
Publicado: (2022) -
Rapid Progression of Multifocal Hepatic Epithelioid Hemangioendothelioma
por: Ressurreição, João, et al.
Publicado: (2015)